Medicare Enrolled

Dr. Lonnie Joe, M.D.

Pulmonary Disease · Southfield, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
22255 GREENFIELD RD, Southfield, MI 48075
2485575227
In practice since 2007 (19 years)
NPI: 1972657260 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Joe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Joe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Joe

Dr. Lonnie Joe is a pulmonary disease specialist in Southfield, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Joe performed 954 Medicare services across 564 unique beneficiaries.

Between the years covered by Open Payments, Dr. Joe received a total of $13,554 from 53 pharmaceutical and/or device companies across 382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Joe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 35% volume in MI $13,554 industry payments

Medicare Practice Summary

Medicare Utilization ↗
954
Medicare services
Top 35% in MI for pulmonary disease
564
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~50 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
261 $93 $205
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
193 $62 $189
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
156 $8 $8
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
75 $36 $65
Chronic care management services
Comprehensive assessment and care planning for patients requiring ongoing chronic care management.
70 $35 $150
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
67 $51 $100
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
44 $12 $55
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $40 $80
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
28 $133 $270
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
21 $39 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,554
Total received (2018-2024)
Avg $1,936/year across 7 years
Top 10% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
382
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,664 (71.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,890 (28.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,231
2023
$1,751
2022
$2,572
2021
$1,330
2020
$31
2019
$265
2018
$1,372

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$3,696
AstraZeneca Pharmaceuticals LP
$684
Novo Nordisk Inc
$349
Regeneron Healthcare Solutions, Inc.
$334
Sumitomo Pharma America, Inc.
$194
GlaxoSmithKline, LLC.
$178
Inari Medical, Inc.
$168
Acera Surgical, Inc.
$122
Lilly USA, LLC
$88
Teva Pharmaceuticals USA, Inc.
$86
ABBVIE INC.
$67
Abbott Laboratories
$46
GENZYME CORPORATION
$42
Actelion Pharmaceuticals US, Inc.
$36
Exact Sciences Corporation
$26
Xeris Pharmaceuticals, Inc.
$24
Otsuka America Pharmaceutical, Inc.
$24
ANI Pharmaceuticals, Inc.
$22
Amgen Inc.
$18
Astellas Pharma US Inc
$14
Janssen Pharmaceuticals, Inc
$14
Top 3 companies account for 75.9% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$4,029
AstraZeneca Pharmaceuticals LP
$1,948
Novo Nordisk Inc
$1,334
Teva Pharmaceuticals USA, Inc.
$828
GlaxoSmithKline, LLC.
$671
Lilly USA, LLC
$438
Regeneron Healthcare Solutions, Inc.
$334
Abbott Laboratories
$287
Gilead Sciences, Inc.
$284
Astellas Pharma US Inc
$274
Sumitomo Pharma America, Inc.
$239
Dexcom, Inc.
$188
Boston Scientific Corporation
$180
Bayer Healthcare Pharmaceuticals Inc.
$179
Bayer HealthCare Pharmaceuticals Inc.
$174
Inari Medical, Inc.
$168
DEXCOM, INC.
$137
Novartis Pharmaceuticals Corporation
$126
Amarin Pharma Inc.
$123
Acera Surgical, Inc.
$122
Global Blood Therapeutics, Inc.
$122
Allergan Inc.
$106
Actelion Pharmaceuticals US, Inc.
$100
AbbVie Inc.
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$67
ABBVIE INC.
$67
Amgen Inc.
$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$50
Janssen Pharmaceuticals, Inc
$49
United Therapeutics Corporation
$47
SANOFI-AVENTIS U.S. LLC
$47
ARBOR PHARMACEUTICALS, INC.
$47
Exact Sciences Corporation
$46
Sunovion Pharmaceuticals Inc.
$46
GENZYME CORPORATION
$42
Pulmonx Corporation
$40
Circassia Pharmaceuticals Inc
$38
E.R. Squibb & Sons, L.L.C.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
Cardiovascular Systems Inc.
$30
Kowa Pharmaceuticals America, Inc.
$27
Xeris Pharmaceuticals, Inc.
$24
Otsuka America Pharmaceutical, Inc.
$24
ANI Pharmaceuticals, Inc.
$22
Shield Therapeutics Inc
$22
Azurity Pharmaceuticals, Inc.
$20
Ironwood Pharmaceuticals, Inc
$18
Insmed, Inc.
$17
Mylan Specialty L.P.
$15
Qiagen, LLC
$13
BOSTON SCIENTIFIC CORPORATION
$12
Biohaven Pharmaceuticals, Inc.
$12
Top 3 companies account for 53.9% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · ALLODERM · ANORO · AREXVY · AUSTEDO · Adempas · Arikayce · Austedo XR · BEVESPI AEROSPHERE · BREZTRI · CHANTIX · CHARTIS CATHETER · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DUPIXENT · DYNAGEN · Descovy · Dexcom G6 Transmitter · Diamondback Peripheral · ELIQUIS · ENTRESTO · EUCRISA · Edarbi · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · GLASSIA · GVOKE HYPOPEN · JARDIANCE · Kerendia · LINZESS · LYRICA · LifeVest · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Myrbetriq · NIOX VERO · NUCALA · NURTEC ODT · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · OXBRYTA · Otezla · Ozempic · PREMARIN · PURIFIED CORTROPHIN GEL · Perforomist · QUANTIFERON-TB GOLD PLUS · REXULTI · RYBELSUS · Restrata Wound Matrix · Rybelsus · S · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SYMBICORT · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULANCE · TRULICITY · TUDORZA PRESSAIR · TYVASO · Truvada · UBRELVY · UZEDY · Utibron · VRAYLAR · Vascepa · Veozah · WATCHMAN Access System · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for pulmonary disease in MI.

Looking for a pulmonary disease specialist in Southfield?
Compare pulmonary diseases in the Southfield area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
113
Per 100K population
8.9
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE HOSPITAL, SOUTHFIELD AND NOVI
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Joe is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 10% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Joe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Joe performed 261 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Joe receive payments from pharmaceutical companies?
Yes. Dr. Joe received a total of $13,554 from 53 companies across 382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Joe's costs compare to other pulmonary diseases in Southfield?
Dr. Joe's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Joe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →